IRESSA (gefitinib, ZD1839) – AstraZeneca Oncology
IRESSA.com - an international educational resource provided by AstraZeneca for patients, health care professionals and journalists providing information on gefitinib (IRESSA)

IRESSA.com is an international educational resource provided by AstraZeneca for patients, health care professionals and journalists providing information on IRESSA (gefitinib)

If you are a US patient or medical professional, please refer to the US IRESSA web site at: www.iressa-us.com

If you are a UK patient or carer, please visit www.patienthealthuk.net
If you are a UK medical professional, please visit www.cancerlineuk.net

日本の医療関係者のページはこちらへ
日本のイレッサをご利用の患者さんはこちらへ

If you are a resident or medical professional in Switzerland, please visit www.iressa.ch
International site for
Health Care Professionals
Patients and Caregivers
Journalists

Please consult your local prescribing information before using IRESSA to treat your patients.

Note: the International site is intended to provide information to audiences outside the USA.

IRESSA is a trade mark of the AstraZeneca group of companies.

International site

Site services